The development of cancer in man requires a series of genetic changes including both mutations and epigenetic alterations. Promoter hypermethylation (epigenetic) leads to the silencing of multiple tumor suppressor genes. Very little is known about mechanisms by which methylation patterns are altered. In the previous period of funding, we focused on inflammation-mediated DNA damage due to the long-standing association between inflammation and the development of cancer. Through a series of studies using in vitro and model systems, we established that reactive molecules generated by activated neutrophils and eosinophils can generated an array of DNA adducts. Among these products are 5-chlorocytosine (5ClC) and 5-bromocytosine (5BrC). We established that proteins containing methyl-binding domains, as well as the human maintenance methyltransferase DNMT1, do not distinguish these adducts from 5-methylcytosine. Therefore, these inflammation- generated DNA damage products could act as fraudulent epigenetic signals resulting in local hypermethylation. Several other adducts were shown to interfere with DNA-protein interactions, potentially leading to loss of methylation. Although multiple studies have measured chlorinated and brominated amino acids associated with human disease, the literature is essentially silent on the presence of 5ClC and 5BrC in human tissues. Several methodological issues are discussed here that have hampered these measurements. As described in Aim 1, we have the reagents and expertise needed to develop the required analytical methods. In human tissues, reactive molecules generated by immune cells must cross the cell membrane and enter the nucleus in order to react with the DNA. Preliminary data support the hypothesis that the formation of chloramines or bromamines might facilitate the delivery of reactive molecules to the nucleus, and that some tertiary amines, including nicotine, might catalyze halogen transfer from the haloamines to cytosine. This hypothesis will be tested in Aim 2 using methods developed in Aim 1. The presence of the 5-halocytosines within promoter regions could serve to both silence transcription and "seed" further methylation. In order to begin testing this hypothesis, we present new methods in Aim 3 that both selectively generate 5-halocytosine in the DNA of human cells in culture and allow its detection at the DNA sequence level.
In Aim 4, we propose to use methods developed in the previous aims to directly measure the presence of 5- halocytosines in the DNA of normal and tumor tissues. We present for the first time, the measurement of 5ClC and 5BrC in human surgical tissues. Completion of the aims proposed here will allow an in- depth examination of the connection between inflammation, DNA damage and cancer etiology.

Public Health Relevance

Our laboratory has been studying how inflammation can result in DNA damage because of the well known correlations between inflammation and cancer. We have studied the types of DNA damage induced by reactive molecules generated during inflammation, and we have identified specific forms of DNA damage including 5-bromocytosine (5BrC) and 5-chlorocytosine (5ClC) that we propose could contribute to aberrant methylation in tumor cells leading to malignant transformation. Results of these studies could lead to rational approaches to reduce cancer incidence.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA084487-10
Application #
8294238
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
2000-05-01
Project End
2017-03-31
Budget Start
2012-04-06
Budget End
2013-03-31
Support Year
10
Fiscal Year
2012
Total Cost
$246,622
Indirect Cost
$85,431
Name
University of Texas Medical Br Galveston
Department
Pharmacology
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Xiong, Lei; Darwanto, Agus; Sharma, Seema et al. (2011) Mass spectrometric studies on epigenetic interaction networks in cell differentiation. J Biol Chem 286:13657-68
Ito, Shinsuke; D'Alessio, Ana C; Taranova, Olena V et al. (2010) Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466:1129-33
Lao, Victoria Valinluck; Darwanto, Agus; Sowers, Lawrence C (2010) Impact of base analogues within a CpG dinucleotide on the binding of DNA by the methyl-binding domain of MeCP2 and methylation by DNMT1. Biochemistry 49:10228-36
Kim, Cherine H; Darwanto, Agus; Theruvathu, Jacob A et al. (2010) Polymerase incorporation and miscoding properties of 5-chlorouracil. Chem Res Toxicol 23:740-8
Valinluck, Victoria; Sowers, Lawrence C (2007) Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers. Cancer Res 67:5583-6
Valinluck, Victoria; Sowers, Lawrence C (2007) Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 67:946-50
Valinluck, Victoria; Liu, Pingfang; Kang Jr, Joseph I et al. (2005) 5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2). Nucleic Acids Res 33:3057-64
Valinluck, Victoria; Tsai, Hsin-Hao; Rogstad, Daniel K et al. (2004) Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 32:4100-8
Rogstad, Daniel K; Heo, Jiyoung; Vaidehi, Nagarajan et al. (2004) 5-Formyluracil-induced perturbations of DNA function. Biochemistry 43:5688-97
Kang Jr, Joseph I; Burdzy, Artur; Liu, Pingfang et al. (2004) Synthesis and characterization of oligonucleotides containing 5-chlorocytosine. Chem Res Toxicol 17:1236-44

Showing the most recent 10 out of 18 publications